{"id":170447,"date":"2025-08-21T07:56:19","date_gmt":"2025-08-21T11:56:19","guid":{"rendered":"https:\/\/44.250.171.167\/?p=170447"},"modified":"2025-08-22T01:00:53","modified_gmt":"2025-08-22T05:00:53","slug":"aarti-drugs-q1-fy26-earnings-results","status":"publish","type":"post","link":"https:\/\/alphastreet.com\/india\/aarti-drugs-q1-fy26-earnings-results\/","title":{"rendered":"Aarti Drugs Q1 FY26 Earnings Results"},"content":{"rendered":"<p>Aarti Drugs Ltd, established in 1984 and part of the $1000 million Aarti Group of Industries, is engaged in manufacturing and selling Active Pharmaceutical Ingredients (APIs), Pharma Intermediates, Specialty Chemicals, as well as pharmaceutical formulations. Presenting below are its <a href=\"https:\/\/www.bseindia.com\/xml-data\/corpfiling\/AttachHis\/8d21b39c-a847-4d03-a99c-732102d5beb2.pdf\" target=\"_blank\" rel=\"noopener\">Q1 FY26<\/a> Earnings Results.<\/p>\n<h2><strong>Q1 FY26 Earnings Results<\/strong><\/h2>\n<ul>\n<li><strong>Revenue:<\/strong> \u20b9591 crore, up 6.49% year-on-year (YoY) from \u20b9555 crore in Q1 FY25.<\/li>\n<li><strong>Total Expenses:<\/strong> \u20b9540 crore, up 5.47% YoY from \u20b9512 crore.<\/li>\n<li><strong>Consolidated Net Profit (PAT):<\/strong> \u20b954 crore, up 63.64% from \u20b933 crore in the same quarter last year.<\/li>\n<li><strong>Earnings Per Share (EPS):<\/strong> \u20b95.86, up 61.88% from \u20b93.62 YoY.<\/li>\n<\/ul>\n<h2><strong>Operational &amp; Strategic Update<\/strong><\/h2>\n<ul>\n<li><strong>Moderate Revenue Growth:<\/strong> Revenues increased by 6.49%, supported by steady demand across API, intermediates, specialty chemicals, and formulation segments.<\/li>\n<li><strong>Controlled Expense Growth:<\/strong> Expenses rose by 5.47%, slightly below revenue growth, aiding margin expansion.<\/li>\n<li><strong><a href=\"https:\/\/www.bseindia.com\/xml-data\/corpfiling\/AttachHis\/8d21b39c-a847-4d03-a99c-732102d5beb2.pdf\" target=\"_blank\" rel=\"noopener\">Substantial Profit Increase<\/a><\/strong><strong>:<\/strong> Net profit and EPS rose sharply by over 60%, reflecting operational leverage and improved cost efficiencies.<\/li>\n<li><strong>Market Position:<\/strong> Aarti Drugs Ltd continues to expand its footprint in pharmaceutical and specialty chemical industries with a robust product portfolio and strategic investments.<\/li>\n<li><strong>Strategic Focus:<\/strong> The company is focused on increasing capacity, improving product mix, and enhancing manufacturing capabilities to drive growth and profitability.<\/li>\n<\/ul>\n<h2><strong>Corporate Developments in Q1 FY26 Earnings<\/strong><\/h2>\n<p>Aarti Drugs Ltd\u2019s <a href=\"https:\/\/www.bseindia.com\/xml-data\/corpfiling\/AttachHis\/8d21b39c-a847-4d03-a99c-732102d5beb2.pdf\" target=\"_blank\" rel=\"noopener\">Q1 FY26<\/a> results underline strong profitability growth driven by revenue traction and disciplined expense management.<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"aligncenter size-full wp-image-170448\" src=\"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/AARTOI.png\" alt=\"AARTIDRUGS Q1 FY26 Earnings Results\" width=\"1489\" height=\"1817\" srcset=\"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/AARTOI.png 1489w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/AARTOI-246x300.png 246w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/AARTOI-839x1024.png 839w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/AARTOI-768x937.png 768w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/AARTOI-1259x1536.png 1259w\" sizes=\"auto, (max-width: 1489px) 100vw, 1489px\" \/><\/p>\n<h2><strong>Looking Ahead<\/strong><\/h2>\n<p>Aarti Drugs Ltd aims to sustain growth through capacity expansions, new product development, and enhanced downstream integration. Continued investments in innovation and quality are expected to support long-term value creation through FY26 and beyond.<\/p>\n<p>Explore the company\u2019s past earnings and latest concall transcripts,<a href=\"https:\/\/44.250.171.167\/symbol\/aartidrugs\/\"> click here<\/a> to visit the AlphaStreet India News Channel.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Aarti Drugs Ltd, established in 1984 and part of the $1000 million Aarti Group of Industries, is engaged in manufacturing and selling Active Pharmaceutical Ingredients (APIs), Pharma Intermediates, Specialty Chemicals, as well as pharmaceutical formulations. Presenting below are its Q1 FY26 Earnings Results. Q1 FY26 Earnings Results Revenue: \u20b9591 crore, up 6.49% year-on-year (YoY) from [&hellip;]<\/p>\n","protected":false},"author":1932,"featured_media":170448,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"jetpack_post_was_ever_published":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[105,392],"tags":[10162],"class_list":["post-170447","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-infographics","category-earnings","tag-pharmaceutical"],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/AARTOI.png","jetpack_likes_enabled":false,"jetpack-related-posts":[{"id":170458,"url":"https:\/\/alphastreet.com\/india\/aarti-pharmalabs-q1-fy26-earnings-results\/","url_meta":{"origin":170447,"position":0},"title":"Aarti Pharmalabs Q1 FY26 Earnings Results","author":"Divyansh_Kasana","date":"August 21, 2025","format":false,"excerpt":"Aarti Pharmalabs Ltd, incorporated in 2019, is a manufacturer of pharmaceuticals and nutraceuticals. Presenting below are its Q1 FY26 Earnings Results. Q1 FY26 Earnings Results Revenue: \u20b9386 crore, down 30.45% year-on-year (YoY) from \u20b9555 crore in Q1 FY25. Total Expenses: \u20b9323 crore, down 33.26% YoY from \u20b9484 crore. Consolidated Net\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"AARTIPAHRM Q1 FY26 Earnings Results","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/APHARM.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/APHARM.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/APHARM.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/APHARM.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/APHARM.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/APHARM.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":169663,"url":"https:\/\/alphastreet.com\/india\/aarti-industries-ltd-q1-fy26-earnings-results-revenue-down-9-5-net-profit-plunges-69-yoy\/","url_meta":{"origin":170447,"position":1},"title":"Aarti Industries Ltd Q1 FY26 Earnings Results \u2013 Revenue Down 9.5%, Net Profit Plunges 69% YoY","author":"Divyansh_Kasana","date":"August 1, 2025","format":false,"excerpt":"Aarti Industries Limited, the flagship company of the Aarti Group, is a leading manufacturer of organic and inorganic chemicals with extensive production facilities across Gujarat (Vapi, Jhagadia, Dahej, Kutch) and Maharashtra (Tarapur). Renowned for its strong market position in NCB-based specialty chemicals, the company supplies key intermediates for diverse industries\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/AARTI.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/AARTI.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/AARTI.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/AARTI.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/AARTI.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/AARTI.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":144684,"url":"https:\/\/alphastreet.com\/india\/earnings-aarti-drugs-ltd-nse-aartidrugs-q4fy23-results-out-total-income-rise-8-5-yoy\/","url_meta":{"origin":170447,"position":2},"title":"Earnings | Aarti Drugs Ltd. (NSE: AARTIDRUGS): Q4FY23 Results Out; Total Income rise 8.5% YoY","author":"Divyansh_Kasana","date":"May 1, 2023","format":false,"excerpt":"Aarti Drugs Ltd. is an Indian pharmaceutical company that specializes in the development, manufacturing, and marketing of active pharmaceutical ingredients (APIs), intermediates, and formulations. The company has a global presence and exports its products to more than 60 countries. Aarti Drugs has a strong focus on research and development and\u2026","rel":"","context":"In &quot;Earnings&quot;","block_context":{"text":"Earnings","link":"https:\/\/alphastreet.com\/india\/category\/earnings\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/4b0b185d-fd09-4e7e-947d-ef141089055f-7.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/4b0b185d-fd09-4e7e-947d-ef141089055f-7.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/4b0b185d-fd09-4e7e-947d-ef141089055f-7.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/4b0b185d-fd09-4e7e-947d-ef141089055f-7.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/4b0b185d-fd09-4e7e-947d-ef141089055f-7.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/4b0b185d-fd09-4e7e-947d-ef141089055f-7.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":170544,"url":"https:\/\/alphastreet.com\/india\/akums-q1-fy26-earnings-results\/","url_meta":{"origin":170447,"position":3},"title":"Akums Q1 FY26 Earnings Results","author":"Divyansh_Kasana","date":"August 25, 2025","format":false,"excerpt":"Akums Drugs & Pharmaceuticals Ltd, established in 2004, is a pharmaceutical contract development and manufacturing organization (CDMO) offering a wide range of pharmaceutical products and services. Presenting below its Q1 FY26 Earnings Results. Q1 FY26 Earnings Results Revenue: \u20b91,024 crore, up 0.49% year-on-year (YoY) from \u20b91,019 crore in Q1 FY25.\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"AKUMS Q1 FY26 Earnings Results","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/AKUMS.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/AKUMS.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/AKUMS.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/AKUMS.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/AKUMS.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/AKUMS.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":179303,"url":"https:\/\/alphastreet.com\/india\/aarti-industries-q3-fy26-earnings-results\/","url_meta":{"origin":170447,"position":4},"title":"Aarti Industries Q3 FY26 Earnings Results","author":"Divyansh_Kasana","date":"February 3, 2026","format":false,"excerpt":"Executive Summary Aarti Industries Ltd reported Q3FY26 revenues of \u20b92,318 crore, up 25.77% YoY, with consolidated net profit surging 189.13% to \u20b9133 crore. Strong sequential volume recovery across energy and agrochem segments, plus tax relief benefits, drove exceptional profitability despite global trade pressures. Revenue & Growth Revenues grew to \u20b92,318\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2026\/02\/AARTI.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2026\/02\/AARTI.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2026\/02\/AARTI.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2026\/02\/AARTI.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2026\/02\/AARTI.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2026\/02\/AARTI.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":142343,"url":"https:\/\/alphastreet.com\/india\/earningsaarti-drugs-ltd-nseaartidrugs-q3fy23-results-out-total-income-rise-4-yoy\/","url_meta":{"origin":170447,"position":5},"title":"Earnings|Aarti Drugs Ltd (NSE:AARTIDRUGS): Q3FY23 Results Out; Total Income rise 4% YoY","author":"Divyansh_Kasana","date":"February 21, 2023","format":false,"excerpt":"Aarti Drugs Ltd (NSE:AARTIDRUGS) is a leading Indian pharmaceutical company that specializes in the manufacture and export of bulk drugs. The company has a diverse product portfolio that includes APIs, intermediates, specialty chemicals, and nutraceuticals. Aarti Drugs is headquartered in Mumbai and has manufacturing facilities located in Tarapur, Vapi, and\u2026","rel":"","context":"In &quot;Earnings&quot;","block_context":{"text":"Earnings","link":"https:\/\/alphastreet.com\/india\/category\/earnings\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]}],"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/170447","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/users\/1932"}],"replies":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/comments?post=170447"}],"version-history":[{"count":0,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/170447\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/media\/170448"}],"wp:attachment":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/media?parent=170447"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/categories?post=170447"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/tags?post=170447"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}